Interestingly, while all comparisons among different tumor types yielded almost perfect discrimination (AUC > 0.9) the performance of IDH wild-type gliomas had relatively poor discrimination from other cancer types (AUC 0.71) and the IDH mutant gliomas also had a less robust accuracy (AUC 0.82). This evidence concerns the gene IDH1 and central nervous system cancer.